Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis - PubMed (original) (raw)

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis

Andrew T Gewirtz et al. J Immunol. 2002.

Abstract

The anti-inflammatory eicosanoid lipoxin A(4) (LXA(4)), aspirin-triggered 15-epi-LXA(4), and their stable analogs down-regulate IL-8 secretion and subsequent recruitment of neutrophils by intestinal epithelia. In an effort to elucidate the mechanism by which these lipid mediators modulate cellular proinflammatory programs, we surveyed global epithelial gene expression using cDNA microarrays. LXA(4) analog alone did not significantly affect expression of any of the >7000 genes analyzed. However, LXA(4) analog pretreatment attenuated induction of approximately 50% of the 125 genes up-regulated in response to the gastroenteritis-causing pathogen Salmonella typhimurium. A major subset of genes whose induction was reduced by LXA(4) analog pretreatment is regulated by NF-kappaB, suggesting that LXA(4) analog was influencing the activity of this transcription factor. Nanomolar concentrations of LXA(4) analog reduced NF-kappaB-mediated transcriptional activation in a LXA(4) receptor-dependent manner and inhibited induced degradation of IkappaBalpha. LXA(4) analog did not affect earlier stimulus-induced signaling events that lead to IkappaBalpha degradation, such as S. typhimurium-induced epithelial Ca(2+) mobilization or TNF-alpha-induced phosphorylation of IkappaBalpha. To establish the in vivo relevance of these findings, we examined whether LXA(4) analogs could affect intestinal inflammation in vivo using the mouse model of DSS-induced inflammatory colitis. Oral administration of LXA(4) analog (15-epi-16-para-fluoro-phenoxy-LXA(4), 10 microg/day) significantly reduced the weight loss, hematochezia, and mortality that characterize DSS colitis. Thus, LXA(4) analog-mediated down-regulation of proinflammatory gene expression via inhibition of the NF-kappaB pathway can be therapeutic for diseases characterized by mucosal inflammation.

PubMed Disclaimer

Cited by

Arachidonic acid and docosahexaenoic acid suppress osteoclast formation and activity in human CD14+ monocytes, in vitro.
Kasonga AE, Deepak V, Kruger MC, Coetzee M. Kasonga AE, et al. PLoS One. 2015 Apr 13;10(4):e0125145. doi: 10.1371/journal.pone.0125145. eCollection 2015. PLoS One. 2015. PMID: 25867515 Free PMC article.
Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models.
Li L, Kashleva H, Dongari-Bagtzoglou A. Li L, et al. Microb Pathog. 2007 Apr;42(4):138-47. doi: 10.1016/j.micpath.2006.12.003. Epub 2007 Jan 19. Microb Pathog. 2007. PMID: 17306958 Free PMC article.
Subgingival Microbiome and Specialized Pro-Resolving Lipid Mediator Pathway Profiles Are Correlated in Periodontal Inflammation.
Lee CT, Li R, Zhu L, Tribble GD, Zheng WJ, Ferguson B, Maddipati KR, Angelov N, Van Dyke TE. Lee CT, et al. Front Immunol. 2021 Jun 10;12:691216. doi: 10.3389/fimmu.2021.691216. eCollection 2021. Front Immunol. 2021. PMID: 34177951 Free PMC article.
Group III phospholipase A2 promotes colitis and colorectal cancer.
Murase R, Taketomi Y, Miki Y, Nishito Y, Saito M, Fukami K, Yamamoto K, Murakami M. Murase R, et al. Sci Rep. 2017 Sep 25;7(1):12261. doi: 10.1038/s41598-017-12434-z. Sci Rep. 2017. PMID: 28947740 Free PMC article.
N-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic.
Calder PC. Calder PC. Lipids. 2003 Apr;38(4):343-52. doi: 10.1007/s11745-003-1068-y. Lipids. 2003. PMID: 12848278 Free PMC article. Review.

Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis - PubMed (original) (raw)